enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Why Sanofi Stock Was Robustly Healthy Today - AOL

    www.aol.com/why-sanofi-stock-robustly-healthy...

    Why Sanofi Stock Was Robustly Healthy Today. Eric Volkman, The Motley Fool. September 3, 2024 at 3:16 PM. Although the latest news from the laboratory was mixed for pharmaceutical company Sanofi ...

  3. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Sanofi

    Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...

  4. Sanofi Pasteur - Wikipedia

    en.wikipedia.org/wiki/Sanofi_Pasteur

    2004: merger of Aventis with and into Sanofi. The new Sanofi-Aventis Group becomes the world's 3rd largest pharmaceutical company, behind Pfizer and GlaxoSmithKline. Aventis Pasteur, the vaccine division of the Sanofi-Aventis Group, changes its name to Sanofi Pasteur. 2008: Sanofi Pasteur acquires Acambis plc, a biotech company.

  5. Sanofi gets two bids valuing its consumer health unit at ...

    www.aol.com/news/sanofi-gets-two-bids-valuing...

    (Reuters) -Sanofi has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 billion euros ($16.74 billion) or more, Bloomberg News reported ...

  6. Roussel Uclaf - Wikipedia

    en.wikipedia.org/wiki/Roussel_Uclaf

    Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi. It was the second largest French pharmaceutical company [6] before it was acquired by Hoechst AG of Frankfurt, Germany in 1997, with pharmaceutical operations combined into the Hoechst Marion Roussel (HMR) division in the United States.

  7. Why Sanofi Stock Flew Higher on Friday - AOL

    www.aol.com/finance/why-sanofi-stock-flew-higher...

    No investor can ignore a crushing bottom-line beat and raised profitability guidance.

  8. Sanofi CEO under pressure to woo investors after ... - AOL

    www.aol.com/news/analysis-sanofi-ceo-under...

    (Reuters) -Sanofi's CEO is under pressure to tell investors how much more he will spend on research and development (R&D) and what the likely pay-offs will be, as he seeks to boost a pipeline of ...

  9. Rhône-Poulenc - Wikipedia

    en.wikipedia.org/wiki/Rhône-Poulenc

    Rhône-Poulenc (French pronunciation: [ʁon pulɛ̃k]) was a French chemical and pharmaceutical company founded in 1928.In 1999, it merged with Hoechst AG to form Aventis.As of 2015, the pharmaceutical operations of Rhône-Poulenc are part of Sanofi and the chemicals divisions are part of Solvay group and Bayer Crop Science.